Education
About Us
Working with TipRanks
Follow Us
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -5.00K | $ -4.00K | $ -2.00K | $ -907.41K |
| Operating Income | $ -18.50M | $ -27.59M | $ -44.40M | $ -115.80M | $ -51.39M |
| EBITDA | $ -18.50M | $ -30.02M | $ -39.75M | $ -93.04M | $ -51.72M |
| Net Income | $ -25.13M | $ -30.15M | $ -35.23M | $ -71.72M | $ -12.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.44M | $ 4.59M | $ 20.05M | $ 27.61M | $ 1.86M |
| Total Assets | $ 3.65M | $ 7.32M | $ 25.82M | $ 32.73M | $ 2.94M |
| Total Debt | $ 0.00 | $ 9.16M | $ 10.53M | $ 518.00K | $ 797.00K |
| Net Debt | $ -1.44M | $ 4.57M | $ -9.53M | $ -27.09M | $ -1.06M |
| Total Liabilities | $ 26.87M | $ 19.05M | $ 18.41M | $ 11.92M | $ 46.71M |
| Stockholders' Equity | $ -23.22M | $ -11.73M | $ 7.41M | $ 20.81M | $ -43.77M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.64M | $ -21.66M | $ -39.77M | $ -37.71M | $ -2.27M |
| Operating Cash Flow | $ -10.64M | $ -21.66M | $ -39.76M | $ -37.70M | $ -2.27M |
| Investing Cash Flow | $ 0.00 | $ -3.00K | $ -10.00K | $ -7.00K | $ -2.00K |
| Financing Cash Flow | $ 7.49M | $ 6.20M | $ 32.21M | $ 63.46M | $ 3.25M |